Ocugen, Inc.
OCGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001372299
In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $589.1K in total
- 1
- 13F holdersQ2 2026, +11 vs. previous quarter
- 147
- 13F valueReported value at the end of Q2 2026
- $222.1M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OCGN, Q2 2026
No superinvestor reported holding OCGN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Ocugen, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 (view filing)9:13 PM ET | Sep 9 | 2 days | Musunuri ShankarChief Executive Officer | SSale | −468.7K | $1.12 | −$525.0K | −9.5%4.49M after | 10b5-1 |
| Sep 11, 2026 (view filing)9:13 PM ET | Sep 9 | 2 days | Musunuri ShankarChief Executive Officer | SSale | −57.3K | $1.12 | −$64.1K | −5.0%1.09M after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Johnson-Greene Treerita EssalimaChief Financial Officer | PPurchase | +21.0K | $1.23 | +$25.8K | +4.2%521.0K after | |
| Dec 2, 2024 (view filing) | Nov 26 | 6 daysLate | Fernandes PrabhavathiDirector | PPurchase | +10.0K | $0.91 | +$9.10K | New position10.0K after | |
| Nov 26, 2024 (view filing) | Nov 22 | 4 days | Castillo KirstenDirector | PPurchase | +25.0K | $0.91 | +$22.8K | +50.0%75.0K after | |
| Jun 16, 2023 (view filing) | Jun 14 | 2 days | Zhang JungeDirector | PPurchase | +200.3K | $0.50 | +$100.1K | +22.8%1.08M after | |
| Feb 17, 2023 (view filing)5:11 PM ET | Feb 16 | 1 day | Musunuri ShankarChief Executive Officer | SSale | −100.0K | $1.08 | −$108.0K | −4.4%2.19M after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Musunuri ShankarChief Executive Officer | SSale | −100.0K | $1.28 | −$128.0K | −4.3%2.23M after | |
| Dec 20, 2022 (view filing) | Dec 16 | 4 days | Musunuri ShankarChief Executive Officer | SSale | −95.8K | $1.43 | −$137.0K | −11.3%752.5K after | |
| Oct 14, 2022 (view filing) | Oct 14 | Same day | Musunuri ShankarChief Executive Officer | SSale | −100.0K | $1.66 | −$166.0K | −11.7%752.5K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Ocugen, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 27,002,933 | $41.3M | 0.00% | +19,697,954+269.7% | Added |
| State Street Corp | 21,469,307 | $32.8M | 0.00% | +11,799,116+122.0% | Added |
| Vanguard Capital Management LLC | 14,372,598 | $22.0M | 0.00% | +568,487+4.1% | Added |
| Millennium Management LLC | 13,943,252 | $21.3M | 0.01% | +216,060+1.6% | Added |
| Geode Capital Management, LLC | 8,871,013 | $13.6M | 0.00% | +4,643,909+109.9% | Added |
| RTW Investments, LP | 6,666,666 | $10.2M | 0.09% | 00.0% | Unchanged |
| UBS Group AG | 5,177,508 | $7.92M | 0.00% | −2,102,812−28.9% | Reduced |
| Ikarian Capital, LLC | 3,962,972 | $6.06M | 0.99% | 00.0% | Unchanged |
| GMT Capital Corp | 3,505,398 | $5.36M | 0.28% | 00.0% | Unchanged |
| Marshall Wace, LLP | 3,410,257 | $5.22M | 0.00% | −4,642,093−57.6% | Reduced |